(2022). α-1 Adrenergic receptor antagonist doxazosin reverses hepatic stellate cells activation via induction of senescence.
Chicago Style (17th ed.) Citationα-1 Adrenergic Receptor Antagonist Doxazosin Reverses Hepatic Stellate Cells Activation via Induction of Senescence. 2022.
MLA (8th ed.) Citationα-1 Adrenergic Receptor Antagonist Doxazosin Reverses Hepatic Stellate Cells Activation via Induction of Senescence. 2022.
Warning: These citations may not always be 100% accurate.
